These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34471349)

  • 1. Effects of Empirical Glucocorticoid Use on Severe Acute Exacerbation of COPD During Hospitalization.
    Wu L; Lan N; Yang X
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2419-2431. PubMed ID: 34471349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Blood eosinophils: a biomarker of response to glucocorticoids and increased readmissions in severe hospitalized exacerbations of COPD].
    Xue J; Cui YN; Chen P; Cai S; Chen L; Dai ZS; Chen Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Jun; 42(6):426-431. PubMed ID: 31189228
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
    Jiao W; Zhang W; Zhang C; Liu Z; Gan Y; Peng Z; Yan G; Deng X; Xue Q; Wu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Sep; 32(9):1061-1066. PubMed ID: 33081891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Eosinophil Levels and Prognosis of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Yu S; Zhang J; Fang Q; Tong Z
    Am J Med Sci; 2021 Jul; 362(1):56-62. PubMed ID: 33617785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.
    Zeiger RS; Tran TN; Butler RK; Schatz M; Li Q; Khatry DB; Martin U; Kawatkar AA; Chen W
    J Allergy Clin Immunol Pract; 2018; 6(3):944-954.e5. PubMed ID: 29153881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.
    Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S
    Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial.
    Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J
    JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.
    Sivapalan P; Lapperre TS; Janner J; Laub RR; Moberg M; Bech CS; Eklöf J; Holm FS; Armbruster K; Sivapalan P; Mosbech C; Ali AKM; Seersholm N; Wilcke JT; Brøndum E; Sonne TP; Rønholt F; Andreassen HF; Ulrik CS; Vestbo J; Jensen JS
    Lancet Respir Med; 2019 Aug; 7(8):699-709. PubMed ID: 31122894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO.
    Pavord ID; Chapman KR; Bafadhel M; Sciurba FC; Bradford ES; Schweiker Harris S; Mayer B; Rubin DB; Yancey SW; Paggiaro P
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1755-1770. PubMed ID: 34163157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study.
    Ichinose M; Nishimura M; Akimoto M; Kurotori Y; Zhao Y; de la Hoz A; Mishima M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2147-2156. PubMed ID: 30034230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.
    Lipson DA; Barnhart F; Brealey N; Brooks J; Criner GJ; Day NC; Dransfield MT; Halpin DMG; Han MK; Jones CE; Kilbride S; Lange P; Lomas DA; Martinez FJ; Singh D; Tabberer M; Wise RA; Pascoe SJ;
    N Engl J Med; 2018 May; 378(18):1671-1680. PubMed ID: 29668352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of re-exacerbation after an index exacerbation of chronic obstructive pulmonary disease in the REDUCE randomised clinical trial.
    Engel B; Schindler C; Leuppi JD; Rutishauser J
    Swiss Med Wkly; 2017; 147():w14439. PubMed ID: 28634972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD exacerbation phenotypes in a real-world five year hospitalisation cohort.
    Jones TPW; Brown J; Hurst JR; Vancheeswaran R; Brill S
    Respir Med; 2020 Jun; 167():105979. PubMed ID: 32421545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
    Wedzicha JA; Banerji D; Chapman KR; Vestbo J; Roche N; Ayers RT; Thach C; Fogel R; Patalano F; Vogelmeier CF;
    N Engl J Med; 2016 Jun; 374(23):2222-34. PubMed ID: 27181606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
    Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of doxofylline as an adjuvant on severe exacerbation and long-term prognosis for COPD with different clinical subtypes.
    Chen MF; He W; Huang DS; Jia H; Zhong ZS; Li N; Li SS; Xia SY
    Clin Respir J; 2023 Sep; 17(9):851-864. PubMed ID: 37562435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.